» Articles » PMID: 35295228

Frequencies and TCR Repertoires of Human 2,4,6-Trinitrobenzenesulfonic Acid-specific T Cells

Overview
Journal Front Toxicol
Date 2022 Mar 17
PMID 35295228
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic contact dermatitis is a widespread T cell-mediated inflammatory skin disease, but monitoring of chemical-specific T cells remains challenging. We here introduce short-term CD154/CD137 upregulation to monitor human T cell responses to the experimental sensitizer 2,4,6-trinitrobenzenesulfonic acid (TNBS). Peripheral blood mononuclear cells (PBMC) from healthy donor buffy coats were TNBS-modified and incubated with unmodified PBMC. After 5 and 16 h, we detected TNBS-specific activated CD154+CD4+ and CD137+CD8+ T cells by multi-parameter flow cytometry, respectively. Activated cells were sorted for restimulation and bulk T cell receptor (TCR) high-throughput sequencing (HTS). Stimulation with TNBS-modified cells (3 mM) induced CD154 expression on 0.04% of CD4+ and CD137 expression on 0.60% of CD8+ memory T cells, respectively (means, = 11-17 donors). CD69 co-expression argued for TCR-mediated activation, which was further supported by TNBS-specific restimulation of 10/13 CD154+CD4+ and 11/15 CD137+CD8+ T cell clones and lines. Major histocompatibility complex (MHC) blocking antibodies prevented activation, illustrating MHC restriction. The high frequencies of TNBS-specific T cells were associated with distinct common changes in the TCR β-chain repertoire. We observed an overrepresentation of tryptophan and lysine in the complementarity determining regions 3 (CDR3) ( = 3-5 donors), indicating a preferential interaction of these amino acids with the TNBS-induced epitopes. In summary, the detection of TNBS-specific T cells by CD154/CD137 upregulation is a fast, comprehensive and quantitative method. Combined with TCR HTS, the mechanisms of chemical allergen recognition that underlie unusually frequent T cell activation can be assessed. In the future, this approach may be adapted to detect T cells activated by additional chemical sensitizers.

Citing Articles

Antigen presentation of post-translationally modified peptides in major histocompatibility complexes.

de Wit A, Bianchi F, van den Bogaart G Immunol Cell Biol. 2024; 103(2):161-177.

PMID: 39609891 PMC: 11792782. DOI: 10.1111/imcb.12839.


Chemical-Specific T Cell Tests Aim to Bridge a Gap in Skin Sensitization Evaluation.

Fritsch N, Aparicio-Soto M, Curato C, Riedel F, Thierse H, Luch A Toxics. 2024; 12(11).

PMID: 39590982 PMC: 11598016. DOI: 10.3390/toxics12110802.


Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8 T cells in persons with previous COVID-19.

Ford E, Mayer-Blackwell K, Jing L, Laing K, Sholukh A, St Germain R Nat Immunol. 2023; 25(1):166-177.

PMID: 38057617 PMC: 10981451. DOI: 10.1038/s41590-023-01692-x.


Investigation of Adverse Reactions in Tattooed Skin through Histological and Chemical Analysis.

Kurz B, Schreiver I, Siewert K, Haslboeck B, Weiss K, Hannemann J Dermatology. 2023; 239(5):782-793.

PMID: 37231944 PMC: 10614264. DOI: 10.1159/000530949.


CD8 T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination.

Ford E, Mayer-Blackwell K, Jing L, Sholukh A, St Germain R, Bossard E Res Sq. 2022; .

PMID: 36263073 PMC: 9580387. DOI: 10.21203/rs.3.rs-2146712/v1.

References
1.
Hochgeschwender U, Weltzien H, Eichmann K, Wallace R, Epplen J . Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones. Nature. 1986; 322(6077):376-8. DOI: 10.1038/322376a0. View

2.
Martin S, Lappin M, Kohler J, Delattre V, Leicht C, Preckel T . Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol. 2000; 115(2):260-6. DOI: 10.1046/j.1523-1747.2000.00038.x. View

3.
Hamann U, Eichmann K, Krammer P . Frequencies and regulation of trinitrophenyl-specific cytotoxic T precursor cells: immunization results in release from suppression. J Immunol. 1983; 130(1):7-14. View

4.
Testi R, Phillips J, Lanier L . T cell activation via Leu-23 (CD69). J Immunol. 1989; 143(4):1123-8. View

5.
Jung J, Rha M, Sa M, Choi H, Jeon J, Seok H . SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat Commun. 2021; 12(1):4043. PMC: 8245549. DOI: 10.1038/s41467-021-24377-1. View